Author Contributions: Ms Roseman and Dr Thombs had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Roseman, Milette, Bero, Coyne, Lexchin, Turner, Thombs.
Acquisition of data: Roseman, Milette, Thombs.
Analysis and interpretation of data: Roseman, Milette, Bero, Coyne, Lexchin, Turner, Thombs.
Drafting of manuscript: Roseman, Thombs.
Critical revision of manuscript for important intellectual content: Roseman, Milette, Bero, Coyne, Lexchin, Turner, Thombs.
Statistical analysis: Roseman, Thombs.
Obtained funding: Thombs.
Administrative, technical, or material support: Thombs.
Study supervision: Thombs.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Lexchin reports being a consultant to a law firm representing Apotex Inc in 2007, the Canadian federal government in a lawsuit challenging the Canadian ban on direct-to-consumer advertising of prescription drugs in 2007-2008, and a consultant to a law firm representing a plaintiff in a case against Allergan in 2010. The other authors report no disclosures for the past 3-year reporting period.
Funding/Support: Ms Roseman and Ms Milette were supported by Frederick Banting and Charles Best Canadian Graduate Scholarships—Master's Awards from the Canadian Institutes of Health Research. Ms Roseman was also supported by a McGill University Provost's Graduate Fellowship and a McGill University Principal's Graduate Fellowship. Ms. Milette was also supported by a Canadian Scleroderma Research Group Studentship (Canadian Institutes of Health Research Strategic Training Initiative in Health Research Grant, SKI 83345) and a McGill University Provost's Graduate Fellowship. Dr Thombs was supported by a New Investigator Award from the Canadian Institutes of Health Research and an Établissement de Jeunes Chercheurs award from the Fonds de la Recherche en Santé Québec. Funds from the Établissement de Jeunes Chercheurs award supported this project.
Role of Sponsors: There was no sponsor involvement in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.
Additional Contributions: We would like to thank Roy C. Ziegelstein, MD, Johns Hopkins University School of Medicine, Baltimore, Maryland, for a critical review of an earlier version of the article; Allison Leavens, BSc, Lady Davis Institute for Medical Research of the Jewish General Hospital, Montréal, Québec, Canada, for proofreading the manuscript; Michael M. Kochen, MD, MPH, PhD, University of Göttingen Medical School, Göttingen, Germany, Matthew J. Czarny, MD, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, and Anna Meijer, MSc, University of Groningen, the Netherlands, for assistance with article retrieval; and Gertrude Brichwood, Jewish General Hospital, Karolina Konieczna, MA, McGill University, Ilya Razykov, McGill University, Anna Seccareccia, Jewish General Hospital, Montréal, Québec, Canada, Okan Taycan, MD, Bolu, Izzet Baysal Mental Health Hospital, Bolu, Turkey, and Philipp Weber, LLB, Rijksuniversiteit Groningen, the Netherlands, for assistance with translation. Ms Konieczna and Mr Weber received compensation of less than $100 each for their work on the project. No other individuals were compensated for their contributions.